TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX): new label to be a 'preview of soon-to-be-published data'

March 16, 2026 9:37 AM

TD Cowen analyst Joshua Jennings reiterated a Buy rating and $190.00 price target on TransMedics Group (NASDAQ: TMDX)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found